Stay updated on Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial

Sign up to get notified when there's something new on the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The study record remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T11:08:10.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T11:39:35.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1, while the study record page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T12:38:42.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal header and footer, replacing the study record content and indicating the page is inaccessible.
    Difference
    19%
    Check dated 2026-09-19T19:16:13.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    - The page revision was updated from v3.6.5 to v3.6.6, signaling a new revision of the page content.
    Difference
    0.1%
    Check dated 2026-08-29T20:07:38.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    The page shows a new revision label (v3.6.5) replacing the previous revision, indicating a minor update to the study page's documentation or metadata rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-08-08T17:02:10.000Z thumbnail image

Stay in the know with updates to Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page.